NeuroPace, Inc.NPCENASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.3%
5Y CAGR+12.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+8.3%/yr
Annual compound
5Y CAGR
+12.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$27.89M+17.9%
2024$23.65M+13.8%
2023$20.78M-5.3%
2022$21.95M+20.5%
2021$18.21M+16.0%
2020$15.70M-14.2%
2019$18.29M-